chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient received the third/booster dose of BNT162b2; Fatigue; Myalgia; Joint pain; Itchiness; Irritability; This is a spontaneous report from a non-contactable consumer, the patient. An adult patient of unknown age and gender received the third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF884) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration on an unknown date and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date, the patient experienced fatigue, myalgia, joint pain, itchiness and irritability. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, myalgia, joint pain, itchiness and irritability were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.
A 2" in diameter red rash formed at the vaccination site.  Rash is red, slightly hard and slightly warm.  We have not treated it.
This spontaneous report as received from a physician via a company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 01-MAR-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB "10Pk 10mcg/1mL SD LLok Cap AD", lot # L001441 with expiration date 17-AUG-2016 (route of administration and anatomical location were not reported). There were no concomitant therapies and adverse effects reported. No product quality complain was involved. On an unspecified date, the RECOMBIVAX HB had six temperature excursion of 33 F (0.5 Celsius Degrees) for 168 hours, 29 F (-1.6 Celsius Degrees) for 256 hours, 30 F (-1.1 Celsius Degrees) for 264 hours, 31 F (-0.5 Celsius Degrees) for 552 hours, 32 F (0 Celsius Degrees) for 352 hours and 34 F (1.1 Celsius Degrees) for 88 hours, respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and type of excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
This is a spontaneous report from a contactable Licensed Practical Nurse communicated to a sales representative, reported for a 16-year-old female patient. A 16-year-old female patient received TRUMENBA (lot number: T52806, Expiry Date: Dec2019), via an unspecified route of administration at right arm on 28Aug2018 at 0.5 ml, single for routine vaccine for Meningococcal B. The patient's medical history was not reported. Concomitant medication included MENACTRA at left arm on 28Aug2018 at single dose for immunization. An LPN, (name withheld) called from the doctor's office and reported to him that a patient who received the meningococcal group b rlp2086  vaccine pre-filled syringe on 28Aug2018 experienced a localized site reaction in Aug2018. The patient had redness, hot, and swelling in the right arm where the vaccine was given. The patient is a sixteen year old female in good health. The outcome of the events was unknown.
Breakthrough case admission after 3 vaccines Pfizer 2/2/21 Lot# EL9261;  Pfizer 2/23/21 Lot# EL9265;  Pfizer 10/3/21 Lot# FE3592
Ringing in my ear.  The ringing in my ear started after the first shot and has been Non -stop.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 41 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: Other medical history: asthma. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
11 days of low-grade fever mixed with high grade fever reaching 103.5 on multiple occasions. chills, heavy fatigue, mental fogginess, spiked-top of the head headache with muscle pain in neck, down spinal column to lumbar region.  Night sweats  A patch of non-painful  blisters on right hip with a few  scattered non-painful blisters on right side of back and front. Around the 13-day point non-painful spots/rash appeared on right lower leg/calf which lead to shin-splint pain in the right leg  with edema of the right foot, ankle and lower leg.  Right hip achiness was also present. The shin-splints incurred swelling.  I experience a few occurrences of low-grade fever after the 11 day point but it would come and go. numbness in right thumb. Achiness in both wrists and hands. I'm still dealing with the edema and shin-splint pain of the right lower leg and a lesser degree of night sweats.
Vaccines given on 10-2-17 (L) deltoid: Hep A - (L) arm; MMRV - RN. (R) deltoid: KINRIX and FLUZONE - RN. Seen in office 10-4-17 with rash on (Rt) deltoid, (Lt) arm and (L) forehead - reddened, localized swelling and itching. Fever/vomiting in less than 24 hours. Unknown if vaccine related.
Pt recv vax on 3/5/98;on same dy pt exp flushing, itching & hives; pt to E.R.; tx=Prednisone, Tagamet & Benadryl
Tolerated vaccine fine. Opened system to discover a dose of pfizer vaccine given 1 week earlier. Contacted patient who says this is incorrect. Department of Health encouraged filling out VAERS
Information has been received from a physician concerning a 20 year old female with medical history of asthma when she was a child, and no known drug reaction, who on 16-NOV-2007 was vaccinated with the first dose of GARDASIL vaccine (yeast). On 17-JAN-2008 the patient was vaccinated with the second dose of GARDASIL vaccine (yeast). On 03-JUL-2008 the patient was vaccinated with the third dose of GARDASIL vaccine (yeast). The physician reported that after the patient completed the GARDASIL vaccine (yeast) series, in July 2008 she started to complained of shortness of breath, palpitations and numbness all over her body. The patient went to the emergency room 4 times in the last month for the symptoms she had experienced daily. The physician also reported that the ER was not able to find the problem. At the time of the report the patient had not recovered. Additional information has been requested.  121/19/2008 ER record received for 8/4/2008 with c/o 1 month hx of SOB and trouble breathing which began after HPV vaccine. Pt left w/o being seen by MD.
Very painful at time of shot. Arm pain after shot. Arm and shoulder pain remaining of day and one day after shot. Next day felt Malaise muscle pain. Felt ok on the second day.
Pt was given flu vaccine on 12/2/2014 and 12/10/2014.
Experienced sore arms for a few days; Some general fatigue for a few days, but no other effects from the booster; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (Experienced sore arms for a few days) and FATIGUE (Some general fatigue for a few days, but no other effects from the booster) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In October 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Experienced sore arms for a few days) and FATIGUE (Some general fatigue for a few days, but no other effects from the booster). At the time of the report, VACCINATION SITE PAIN (Experienced sore arms for a few days) and FATIGUE (Some general fatigue for a few days, but no other effects from the booster) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, Antibody test: 440 440 S antibodies. In December 2021, Antibody test: 2500 2500 S antibodies.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.  The patient was not tested positive for the N antibodies indicating that she did not had COVID.
Asthma; Hearing loss(felt clogged, electronic vibration, white noise, crackling sounds); Weird noises in her left ear; This spontaneous case was reported by a consumer and describes the occurrence of DEAFNESS UNILATERAL (Hearing loss(felt clogged, electronic vibration, white noise, crackling sounds)) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced TINNITUS (Weird noises in her left ear). On 15-Mar-2021, the patient experienced DEAFNESS UNILATERAL (Hearing loss(felt clogged, electronic vibration, white noise, crackling sounds)) (seriousness criterion medically significant). On an unknown date, the patient experienced ASTHMA (Asthma). On 22-Mar-2021, DEAFNESS UNILATERAL (Hearing loss(felt clogged, electronic vibration, white noise, crackling sounds)) had resolved. At the time of the report, TINNITUS (Weird noises in her left ear) and ASTHMA (Asthma) outcome was unknown.            Concomitant information not provided  On 14/Mar/2021, she had weird noises in her left ear. The next day she had hearing loss (felt clogged, electronic vibration, white noise, crackling sounds). On 17/Mar/2021 she went to ENT who told her she was not the first patient of the day that came in with hearing loss due to vaccination. She was diagnosed with hearing loss of 60 percent in left ear for word recognition. Her speech reception threshold in left ear was AIR 30 decibels (dB), pure tone average left Air 28 decibels Hearing Level (dB HL), bone 25 dB HL. Her right ear was normal at Air 17 dB HL. She saw a specialist the same day and was examined. He gave her 60 mg/day of prednisone for 7 days. She went back a week later, and her results were word recognition at 100%, but she still has clicking and white noise in the ear. Speech recognition air 20dB pure tone average air was 18 dB HL, bone 17 dB HL. Tympanogram diagnostics done on 17/Mar/2021 showed ear canal volume left 1.25, right 2.27. A week later it was 1.66 in left, right was 1.43.  Action taken with mRNA-1273 in response to the events was not Applicable.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD21-082695, MOD21-082690, US-MODERNATX, INC.-MOD-2021-092733, US-MODERNATX, INC.-MOD-2021-092583 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. MOD21-082695: MOD21-082690: US-MODERNATX, INC.-MOD-2021-092733: US-MODERNATX, INC.-MOD-2021-092583:Crosslinked (MOD21-082668)
Fatigue, chills, body aches, headache. Tylenol only for treatment with little relief. Symptoms started 8-10 hours after injection and lasted 12-15 hours with lingering headache and fatigue for another 4 hours.
Patient was administered 0.2ml as a booster dose. When contacted patient did not complain of any side effects.
Patient was one of five patients who received the MENVEO vaccine from a box where a vial of diluent was found to be "left over." After making inquiries, it is impossible to tell which of the five may have received an incomplete vaccine (the MENVEO powder mixed with an incorrect diluent). After contacting the manufacturer of the vaccine to find out proper recommendations, the parents were called and asked to bring in the child for a repeat vaccination as soon as possible. There was no harmful effect from this event other than the child having to receive another shot.
The day after vaccination, patient developed a painful left L2-dermatomal Zoster rash.
Started with bodyaches and then I got very cold. Started shaking, continued for about 3 hours  of which 20 minutes was violent shaking . The chills started about 10 PM, fell asleep about 3 AM. Woke up the next morning tired but no chills. 36 hours later I am back to normal.
This spontaneous report was received from a healthcare worker and refers to a 4 year old patient of unknown gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 27-AUG-2015, the patient was vaccinated with an improperly stored PROQUAD (Merck) lot # L010142, expiration date: 24-SEP-2016 (dose, therapy type, route of administration and anatomical location were not reported). There were no adverse effects reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Pt started having pounding of the heart a few days after vaccine.  Occurred every few days for 10 minutes at a time. No other activity correlation.  Saw patient 2 weeks after symptoms began.  Exam normal. Still having pounding of the heart but less often.
feels a fever coming on/fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (feels a fever coming on/fever) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced PYREXIA (feels a fever coming on/fever). At the time of the report, PYREXIA (feels a fever coming on/fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided. No treatment medications were provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 16-Sep-2021: Follow up received on 16 Sep 2021 contains updated consent information.
causing pain  down the side of my left breast; there is a lump under my armpit on the left side; and immediately after it my whole arm hurt from shoulder then it went to my thumb an; This spontaneous case was reported by an other health care professional and describes the occurrence of BREAST PAIN (causing pain  down the side of my left breast), LYMPHADENOPATHY (there is a lump under my armpit on the left side) and MYALGIA (and immediately after it my whole arm hurt from shoulder then it went to my thumb an) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (causing pain  down the side of my left breast), LYMPHADENOPATHY (there is a lump under my armpit on the left side) and MYALGIA (and immediately after it my whole arm hurt from shoulder then it went to my thumb an). At the time of the report, BREAST PAIN (causing pain  down the side of my left breast), LYMPHADENOPATHY (there is a lump under my armpit on the left side) and MYALGIA (and immediately after it my whole arm hurt from shoulder then it went to my thumb an) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided No treatment received by the patient
"Bright red, swollen, hot lump on arm (8cm X 8cm X 9cm)-not especially tender."
Pt recvd DTP/OPV/HIB 10SEP91 & was OK until 1230AM wake cried until 6AM; cry was high pitched @ times episodes of holding breath; no temp taken but pt felt hot, given APAP; 1SEP91 pt t102, irritable, swelling @ both inject sites, has cold;
Parent called stating child was vomiting. We offered the parent to bring the child back to the office or report to the emergency room. Patient parent decided to go to the emergency room.
Palm size hot swelling at injection site with pustules inside the swollen area on the first day of the injection.  Then outbreak of pustules scattered over  body.  Then total body itching after pustules cleared.  Two weeks of steroids to counteract itching.  Now flushed and feverish and all over pain.  Weakness and lethargy, dizzy and days of school missed.
The patient is unsure of exactly when the event started. She just happened to look at her arm when she was working and saw a rash. He did not describe the rash as being painful, warm or itchy. It look like a solid red, raised rash. It looked similar to a cellulitis. We drew a line around the rash and asked her to see a doctor if it grew outside the line.
yesterday had the second dose of the pfizer vaccine, 22 days after the first.  i had no reaction to the first other than slight discomfort at the injection site the next day, like any other vaccination.  This morning i awoke feeling fine, other than a similar discomfort as to the first dose.  However I saw on my left arm, in which i rec'd the injection,  that nowhave an odd, streaky deep purple rash or bruise about  9cm at the longest point, 2.5cm width.  It is not sore to the touch but have never had anything like it.
This spontaneous report as received from a registered nurse refers to multiple patients of unknown age and gender. Patients' concurrent conditions and medical history were not reported. On an unknown dates, the patients received doses of improperly stored PNEUMOVAX 23 (lot# K006681, expiration date: 21-OCT-2015 or lot# K008409, expiration date: 04-MAR-2016), dose and route were not reported. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Shortness of breath, runny nose, racing heart, headache, shivering, ringing ears, tingling hands and fingers, paranoia, nightmares, hallucinations, panic attacks
nauseous; sick; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous) and ILLNESS (sick) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), MORPHINE, PROCATEROL, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A), METRONIDAZOLE (DIAZOLE [METRONIDAZOLE]) and OMEPRAZOLE (PROPIZOLE) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (nauseous) and ILLNESS (sick). At the time of the report, NAUSEA (nauseous) and ILLNESS (sick) outcome was unknown.            Concomitant medications : Flexural Multi Vitamins No treatment medications was provided by the reporter   This case was linked to MOD-2021-230033 (Patient Link).
Information has been received on 14-NOV-2018 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 01-NOV-2014, the patient's healthcare provider at a medical center administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 29-APR-2017, the patient was treated by the patient's healthcare providers at a hospital emergency department for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Had been running a fever and been a bit fussy shortly after shots, but at 7:15 AM on the 19th she threw up all over until she was dry heaving she wouldn't eat either prior to that when I frayed to feed her at 6AM.  I called the clinic and the doctor saw her and told us to continue with the ibuprofen and only let her have small amounts of formula at a time.
Started having irregular heartbeat/skipped beats a few days after the first vaccine and again after the second vaccine. May be a coincidence, but I had been arrhythmia-free for over six years after cardiac ablation, and after both shots the irregularity started a few days after the vaccine and lasted for about a week. This was not in any way debilitating, just annoying and a little scary. Only other side effect was sore hour and ~12 hours of mild flu-like symptoms from 30-42 hours after 2 vaccine.